The Genomics and Metagenomics of Asthma Severity (GEMAS) Study: Rationale and Design

The Genomics and Metagenomics of Asthma Severity (GEMAS) Study: Rationale and Design

Asthma exacerbations are a major contributor to the global disease burden, but no significant predictive biomarkers are known. The Genomics and Metagenomics of Asthma Severity (GEMAS) study aims to assess the role of genomics and the microbiome in severe asthma exacerbations. Here, we present the de...

Full description

Bibliographic Details
Main Authors: Javier Perez-Garcia, José M. Hernández-Pérez, Ruperto González-Pérez, Olaia Sardón, Elena Martin-Gonzalez, Antonio Espuela-Ortiz, Elena Mederos-Luis, Ariel Callero, Esther Herrera-Luis, Paula Corcuera, Inmaculada Sánchez-Machín, Paloma Poza-Guedes, Luis Manuel González García, Purificación Ramírez-Martín, Lorenzo Pérez-Negrín, Hemily Izaguirre-Flores, Javier Barrios-Recio, Eva Pérez-Rodríguez, Julia Alcoba-Florez, José A. Cañas, José M. Rodrigo Muñoz, Victoria del Pozo, Javier Korta-Murua, Lina I. Pérez Méndez, Mariano Hernandez-Ferrer, Jesús Villar, Fabian Lorenzo-Diaz, Maria Pino-Yanes
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Personalized Medicine
Subjects:
asthma
exacerbation
microbiome
genetics
precision medicine
respiratory disease
Online Access:https://www.mdpi.com/2075-4426/10/3/123

Internet

https://www.mdpi.com/2075-4426/10/3/123

Similar Items